» Download Public Reports
About 300 reports
- Company report
- January 2013
- 2 pages
... Europe. The center runs clinical trials of pharmaceuticals in poland and also coordinates such trials for astrazeneca around the world. The investment is expected to provide 120 new jobs by the end ...
December 2012
... A71 backlog increased 20% year on year to $2.8 Billion. A71 guidance increased to reflect the acquisition of the clinical trial service division of cross country healthcare, inc. To revenue ...
April 2013
... Health will drive forward public health knowledge, which is a key issue for all governments." The french-german advanced translational drug discovery center is a unique project of public- private ...
December 2012
... And diagnostic activities and for key members of valirx S management team to expedite the product development of val201 towards clinical trials. Fund raising during the year, the company achieved two successful ...
February 2013
... As a whole and to seek shareholder approval for the placings. Background to and reasons for the placings e-therapeutics is a drug discovery and development company with a proprietary platform technology ...
December 2012
... Activity. Multiple parties are conducting detailed technical and commercial evaluations of sng001. We aim to finalise arrangements with a primary partner to enable commencement of follow-on clinical trial ...
December 2012
... Include, among others, risks associated with product discovery and development, uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety ...
January 2013
... Efficacious safe safe efficacious differentiated safe efficacious differentiated reimbursable clinical trials at az critical to the development of new medicines global programs will have to reflect ...
February 2013
... Is it important to irish patients Clinical research infrastructure patient S perspective We are talking to companies about clinical trials, as well as being on the cutting edge of new breakthroughs ...
February 2013
... Are the same Using of the cros with strong regional presence can decrease the costs Logistics issues (shipment of clinical trial materials to the distant sites: shipment of biosamples to the central lab ...
» Purchase Premium Reports
(From $ 125 - $ 750)
About 100 reports
- $ 750
- Company report
- May 2013
- by Global Data
Summary Medispec LTD, (Medispec) is a medical device manufacturing company. The company develops, manufactures and markets non invasive medical devices for the cardiovascular, urology, orthopedic, physiotherapy, ...
May 2013
$ 750
Summary Teknimed S.A. (Teknimed) is a medical device company. The company develops and manufactures orthopedic products. Its products include acrylic bone cements, resorbable obturators, bone substitutes, ...
April 2013
$ 750
Summary Spineway is a medical device company. It specializes in design, development, manufacture and supply of implants for spinal column surgery. The company's products include posterior fusion system, ...
April 2013
$ 750
Summary Kuros Biosurgery AG (Kuros) is a medical technology company.The company develops injectable biomaterial products for the trauma and wound care markets. It was formed as a spin-off from the Swiss ...
April 2013
$ 250
Summary Axxam SpA (Axxam) is a biotechnology company. The company conducts discovery research programs for the life science industry. Its technologies have developed photoproteins such as Photina and i-Photina. ...
April 2013
$ 250
Summary Clinquest Group, B.V. (Clinquest) is a contract research organization, based in Netherlands. The company is involved in consulting services for drug discovery and development, implementation, post-approval ...
April 2013
$ 250
Summary Aptuit LLC (Aptuit) is a healthcare service providing company. The company provides a range of drug development services ranging from discovery to proof-of-concept, carrying out research, development ...
